Skip to main content

Prenetics Global Ltd

corporate_fare Company Profile

Prenetics Global Ltd

PRE·NASDAQ·Life Sciences·CIK 0001876431

Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into health, wellness, and genetic predispositions. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Prenetics Global Ltd (NASDAQ:PRE) is a publicly traded company in the Life Sciences sector. Wiseek monitors PRE SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Prenetics Appoints Longevity Expert Dr. Darshan Shah to Board, Reinforcing IM8 Growth Strategy
  • Prenetics Global Completes $70M Insighta Sale to Tencent, Bolstering Liquidity and Strategic Focus
  • Prenetics Divests Europa Business for Up to $13M, Sharpens Focus on High-Growth IM8 Brand
  • Prenetics Reduces Potential Dilution by 43% Through Warrant Exchange Program

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$92.39M
Net Income
-$39.98M
Diluted EPS
-$2.68
Op. Cash Flow
-$21.83M
Free Cash Flow
-$22.03M
Gross Profit
$48.79M
Operating Income
-$44.48M
Cash & Equivalents
$32.13M
Debt / Equity
0.00×
Net Margin
-43.3%
Source: 20-F · filed 2026-04-30 · accession 0001628280-26-028623

Insider Transactions

PRE files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$18.63 +0.37% today
52-week range · as of 2026-07-14 $7.17 – $23.63
Market cap
$307.29M
Volume
119.2K (0.6× avg)
3-mo avg 212.8K
Live data · 2026-07-29 09:34 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed PRE - Filings & News (Page 2)

PRE
Feb 17, 2026, 4:33 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $21.74
Real-time Price: $18.63 info
Change: -$3.11 (-14%) info
Market Cap: $307.287M info
PRE
Feb 17, 2026, 8:29 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $22.19
Real-time Price: $18.63 info
Change: -$3.56 (-16%) info
Market Cap: $307.287M info
PRE
Jan 06, 2026, 8:04 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.85
Real-time Price: $18.63 info
Change: +$2.78 (+18%) info
Market Cap: $307.287M info
PRE
Jan 05, 2026, 8:21 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $16.21
Real-time Price: $18.63 info
Change: +$2.42 (+15%) info
Market Cap: $307.287M info